Introduction: Primary melanoma of the lung has been considered an extremely rare and highly aggressive malignancy that accounts for 0.01% of all primary lung tumors. Molecular studies, as well as pertinent clinical history, have since brought into question whether these tumors truly represent primary lesions of the lung. The current study evaluates a series of four melanomas of the lung to assess whether primary melanoma of the lung is truly a diagnostic consideration, or if these cases represent metastases of other primary sites. Methods: The pathology archives at the University of Chicago Medical Center were searched for patients who underwent robotic or endobronchial ultrasound-guided fine needle aspiration from 2018 to 2024. Clinicopathologic data, including demographics, fine needle aspiration results, and follow-up information including molecular studies and surgical resections, were collected from patients’ electronic medical record. Results: In total 15,959 robotic-guided/endobronchial ultrasound-guided FNAs were reviewed, with 2 cases (0.0001%) being metastatic melanoma with no known cutaneous primary after immunohistochemical and molecular studies. Both patients had molecular studies performed. Notable mutations included BRAF, TERT, NRAS, CDKN2A, and NF1, which are frequently seen in cutaneous melanomas. High tumor mutational burden (UV signature with >98 mutations per megabase) was also detected by next-generation sequencing. Conclusion: Based upon molecular signatures, clinical history, and presumed lack of precursor cell type within the bronchial epithelium, melanomas arising within the lung are most likely metastatic tumors.

1.
Cossu
A
,
Casula
M
,
Cesaraccio
R
,
Lissia
A
,
Colombino
M
,
Sini
MC
, et al
.
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy
.
Eur J Cancer Prev
.
2017
;
26
(
3
):
263
7
.
2.
Wilson
RW
,
Moran
CA
.
Primary melanoma of the lung: a clinicopathologic and immunohistochemical study of eight cases
.
Am J Surg Pathol
.
1997
;
21
(
10
):
1196
202
.
3.
Paliogiannis
P
,
Fara
AM
,
Pintus
G
,
Abdel-Rahman
WM
,
Colombino
M
,
Casula
M
, et al
.
Primary melanoma of the lung: a systematic review
.
Med Kaunas
.
2020
;
56
(
11
):
576
.
4.
Kadri
S
,
Long
BC
,
Mujacic
I
,
Zhen
CJ
,
Wurst
MN
,
Sharma
S
, et al
.
Clinical validation of a next‐generation sequencing genomic oncology panel via cross‐platform benchmarking against established amplicon sequencing assays
.
J Mol Diagn
.
2017
;
19
(
1
):
43
56
.
5.
Talevich
E
,
Shain
AH
,
Botton
T
,
Bastian
BC
.
CNVkit: genome‐wide copy number detection and visualization from targeted DNA sequencing
.
PLoS Comput Biol
.
2016
;
12
(
4
):
e1004873
.
6.
Parilla
M
,
Kadri
S
,
Patil
SA
,
Fitzpatrick
C
,
Ritterhouse
L
,
Segal
J
, et al
.
Integrating a large next‐generation sequencing panel into the clinical diagnosis of gliomas provides a comprehensive platform for classification from FFPE tissue or smear preparations
.
J Neuropathol Exp Neurol
.
2019
;
78
(
3
):
257
67
.
7.
Biernacka
A
,
Linos
KD
,
DeLong
PA
,
Suriawinata
AA
,
Padmanabhan
V
,
Liu
X
.
A case of S-100 negative melanoma: a diagnostic pitfall in the workup of a poorly differentiated metastatic tumor of unknown origin
.
CytoJournal
.
2016
;
13
:
21
.
8.
Alexandrov
LB
,
Kim
J
,
Haradhvala
NJ
,
Huang
MN
,
Tian Ng
AW
,
Wu
Y
, et al
.
The repertoire of mutational signatures in human cancer
.
Nature
.
2020
;
578
(
7793
):
94
101
.
9.
Jin
SG
,
Padron
F
,
Pfeifer
GP
.
UVA radiation, DNA damage, and melanoma
.
ACS Omega
.
2022
;
7
(
37
):
32936
48
.
10.
McGovern
VJ
.
Spontaneous regression of melanoma
.
Pathology
.
1975
;
7
(
2
):
91
9
.
11.
Marchioni
A
,
Lasagni
A
,
Busca
A
,
Cavazza
A
,
Agostini
L
,
Migaldi
M
, et al
.
Endobronchial metastasis: an epidemiologic and clinicopathologic study of 174 consecutive cases
.
Lung Cancer
.
2014
;
84
(
3
):
222
8
.
12.
Fishbach
S
,
Steinhardt
G
,
Zhen
CJ
,
Puranik
R
,
Segal
JP
,
Cipriani
NA
.
High rates of ultraviolet-signature mutations in squamous cell carcinomas of the parotid gland and prognostic implications
.
Head Neck Pathol
.
2022
;
16
(
1
):
236
47
.
You do not currently have access to this content.